Savara Inc
SVRA$544M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaAUSTIN
Drugs in Pipeline
4
Phase 3 Programs
2
Upcoming Catalysts
2
Next Catalyst
Aug 12, 2026
7wMarket Overview
Stock performance and key metrics
SVRA News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
Vancomycin inhalation powder
MRSA
Molgramostim
Autoimmune Pulmonary Alveolar Proteinosis
Inhaled molgramostim
Mycobacterium Infections, Nontuberculous
Vancomycin hydrochloride inhalation powder
Cystic Fibrosis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Vancomycin inhalation powder | Phase 3 | MRSA | - | - |
Molgramostim | Phase 3 | Autoimmune Pulmonary Alveolar Proteinosis | - | - |
Inhaled molgramostim | Phase 2 | Mycobacterium Infections, Nontuberculous | - | - |
Vancomycin hydrochloride inhalation powder | Phase 2 | Cystic Fibrosis | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply